Blog

Updates on the Bard PowerPort Lawsuit

The Bard PowerPort is an implanted port catheter designed to facilitate the intravenous delivery of fluids or medications. However, inherent design and manufacturing flaws have led to serious injuries such…
Filed Under: Industry Advice

Updates on the Depo-Provera Lawsuit

Depo-Provera, widely used as a female contraceptive injection for over three decades, has been linked to a significantly increased risk for development of meningiomas, a type of brain tumor. Numerous…
Filed Under: Industry Advice

Updates on the Paraquat Lawsuit

The paraquat lawsuit continues to evolve, with new cases and legal decisions impacting those affected by the commercial-strength herbicide. This blog provides a detailed overview and the latest updates on…
Filed Under: Industry Advice

Updates on the PFAS Contamination Lawsuit

Per- and polyfluoroalkyl substances, commonly known as PFAS, are a group of human-made chemicals that have been used in a multitude of industries for their grease and water-resistant properties. The…
Filed Under: Industry Advice

Q1 2025 Events

The Broughton Partners team is kicking off the first quarter of the year with a busy conference schedule. We’re excited to connect with legal professionals and explore how we can…
Filed Under: Conferences

Updates on NEC Baby Formula Lawsuit

Across the United States, Necrotizing Enterocolitis (NEC) formula lawsuits are being pursued by families of premature infants who were diagnosed with NEC after being fed Similac or Enfamil baby formula.…
Filed Under: Industry Advice